Avalo Therapeutics, Inc.
$928.87M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15743.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17497.92x
$19.25Latest market snapshot
Implied fair value · at FFIV's multiple
$0.01100.0% below market
0.00 AVTX revenue / share×7.16x FFIV P/S=$0.01
Market $19.25Implied $0.01
FFIV · current priceP/S 7.16x
$390.51Latest market snapshot
Implied fair value · at AVTX's multiple
$954,220.84244,252.5% above market
54.53 FFIV revenue / share×17497.92x AVTX P/S=$954,220.84
Market $390.51Implied $954,220.84